NCT07491653 (GO-FAR) is a NA clinical trial of GO-FAR in Prediabetes, sponsored by University of Oklahoma.

Who is sponsoring NCT07491653?

NCT07491653 is sponsored by University of Oklahoma.

What drugs are being tested in NCT07491653?

Interventions in NCT07491653: GO-FAR.

What condition does NCT07491653 study?

NCT07491653 studies Prediabetes.

Is NCT07491653 still recruiting?

NCT07491653 is currently recruiting now. Last updated 30 March 2026.

Last reviewed 2026-03-30 · How we verify

NCT07491653: GO-FAR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fiber mHealth Intervention for Prediabetes

Recruiting now NA Last updated 30 March 2026

What this trial tests

NA trial testing GO-FAR in Prediabetes in 80 participants. Currently enrolling.

Timeline

31 March 2026

Primary endpoint
1 July 2028

1 July 2028

Quick facts

Lead sponsor	University of Oklahoma
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	80
Start date	31 March 2026
Primary completion	1 July 2028
Estimated completion	1 July 2028
Sites	1 location across United States

Drugs / interventions tested

GO-FAR

Conditions studied

Prediabetes — all drugs for Prediabetes →

Sponsor

University of Oklahoma

Who can join

Adults 18 to 39, any sex, with Prediabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-arm feasibility trial to examine an mHealth intervention that combines high fiber education, home-delivered high fiber foods, and use of continuous glucose monitors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prediabetes

Currently open trials in the same condition.

NCT07529366 — Pharmacist-Led Continuous Glucose Monitoring for Prediabetes · recruiting
NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
NCT07478263 — Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes · NA · recruiting
NCT07372729 — Smartwatch-based Intervention for Cardiovascular Health (SWITCH) · NA · recruiting
NCT07477249 — Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment · NA · recruiting

Other University of Oklahoma trials

Trials by the same sponsor.

NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
NCT07494773 — Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection · Phase 1, PHASE2 · not yet recruiting
NCT07014605 — Smoking Cessation Program for Lao People With HIV · NA · not yet recruiting
NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07146893 — Feasibility Study for Repurposing RET Inhibitors · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07491653 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oklahoma
Last refreshed: 30 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07491653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing